Abata Therapeutics
Cambridge, MA
Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory diseases.
abatatx.comCompany Details
Founded
- 2021
Employees
- Between 20 - 100 employees
Raised
- $95,000,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Samantha Singer
Founders
- Richard Ransohoff
Company Collections
These are collections Abata Therapeutics is a part of. Click on the collection name to view similar companies.